Invention Grant
- Patent Title: Factor IX polypeptide mutant, its uses and method for its production
-
Application No.: US15989665Application Date: 2018-05-25
-
Publication No.: US10465180B2Publication Date: 2019-11-05
- Inventor: Paolo Simioni
- Applicant: uniQure biopharma B.V.
- Applicant Address: NL Amsterdam
- Assignee: uniQure biopharma B.V.
- Current Assignee: uniQure biopharma B.V.
- Current Assignee Address: NL Amsterdam
- Agency: DLA Piper LLP (US)
- Priority: ITBO2008A0564 20080915; ITBO2009A0275 20090506
- Main IPC: C12N9/64
- IPC: C12N9/64 ; A61K38/48
Abstract:
Disclosed are a modified FIX (factor IX) polypeptide comprising a leucine, cysteine, aspartic acid, glutamic acid, histidine, lysine, asparagine, glutamine or tyrosine in position 338; pharmaceutical preparations containing said modified FIX polypeptide; a nucleotide sequence coding for the modified FIX polypeptide; and a method for producing the modified FIX polypeptide.
Public/Granted literature
- US20180258413A1 FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND METHOD FOR ITS PRODUCTION Public/Granted day:2018-09-13
Information query
IPC分类:
